Khyobeni Mozhui
benimoz.bsky.social
Khyobeni Mozhui
@benimoz.bsky.social
My research areas: genomics, epigenetics, biology of aging, health disparities, etc.

My favorite things: running, sunsets, walks with audiobook, e-ink devices, wearable tech, and not-winter-time.
[views/opinions are my own]
Shouldn’t there also be a similar device to screen for HPV in males? In many countries, HPV is spread primarily by males… 🤷🏻‍♀️
May 9, 2025 at 4:20 PM
We hope that our work will contribute towards developing a more personalized and holistic approach towards gender-affirming medical care that also recognizes the complex interplay between hormonal treatment, social factors, and health outcomes. (3/3)
www.medrxiv.org/content/10.1...
Tracking Epigenetic Biomarkers of Health and Aging During the Initial Year of Gender-Affirming Hormone Therapy
Gender-affirming hormone therapy (GAHT) is a necessary treatment for many transgender people, and there is a critical need to further improve treatment experience and mitigate possible risks. Here we ...
www.medrxiv.org
March 9, 2025 at 7:07 PM
We found interesting contrasts between feminizing and masculinizing treatments, but with marked inter-individual differences that underscore the uniqueness of each person's journey and physiological response. (2/3)
March 9, 2025 at 7:07 PM
“6 new TTI at NIA… CSR… hit..” that’s very cryptic. Are you saying 6 tenure track investigators lost their jobs? And some CSR officers also lost jobs?
February 17, 2025 at 5:18 AM
Reposted by Khyobeni Mozhui
Also, please repost and follow.

We'd like to make sure as many scientists, physicians, and members of the public see these posts as possible.
January 30, 2025 at 5:39 PM
Their goal is to destroy academia, yes.
Their agenda also includes crippling the sciences, and scrubbing all empirical data that conflicts with their ideology-based scientific “truths”.
February 9, 2025 at 12:00 AM
The dementia has gone far in this one.
February 8, 2025 at 3:38 PM